Prudential Financial’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.81M Buy
189,315
+9,925
+6% +$357K 0.01% 771
2025
Q1
$7.07M Buy
179,390
+10,815
+6% +$426K 0.01% 711
2024
Q4
$5.07M Sell
168,575
-136,762
-45% -$4.12M 0.01% 871
2024
Q3
$7.14M Buy
305,337
+219,748
+257% +$5.14M 0.01% 819
2024
Q2
$1.52M Buy
85,589
+75,035
+711% +$1.33M ﹤0.01% 1580
2024
Q1
$161K Sell
10,554
-1
-0% -$15 ﹤0.01% 2491
2023
Q4
$180K Buy
10,555
+330
+3% +$5.64K ﹤0.01% 2457
2023
Q3
$85.5K Sell
10,225
-45,032
-81% -$376K ﹤0.01% 2455
2023
Q2
$1.37M Sell
55,257
-88,338
-62% -$2.19M ﹤0.01% 1642
2023
Q1
$2.16M Buy
+143,595
New +$2.16M ﹤0.01% 1288
2022
Q1
Sell
-9,391
Closed -$327K 2692
2021
Q4
$327K Sell
9,391
-1,101
-10% -$38.3K ﹤0.01% 2368
2021
Q3
$328K Sell
10,492
-693
-6% -$21.7K ﹤0.01% 2285
2021
Q2
$434K Buy
11,185
+310
+3% +$12K ﹤0.01% 2181
2021
Q1
$524K Buy
10,875
+566
+5% +$27.3K ﹤0.01% 2115
2020
Q4
$536K Buy
10,309
+661
+7% +$34.4K ﹤0.01% 2034
2020
Q3
$259K Buy
+9,648
New +$259K ﹤0.01% 2214